Innovative solutions to the greatest challenges in pharmaceutical development

21 - 23 March 2022

Thank you to everyone who attended the 2021 Global Drug Delivery & Formulation Virtual Summit!

The 2021 Virtual Summit covered both small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

BOOK FOR €1095

2021 Speakers

Lena Mareczek (1)

Merck

PhD candidate

Gonçalo Rebelo de Andrade

Nanoform

Chief of Business Operations

Chairperson Room 1, Day 2

Andrea Benassi

Chiesi

CMC – Chemistry Manufacturing & Controls, Drug Product manufacturing & Innovation, New Technology & Innovation Scientist

Jian Bao

ZY Therapeutics

CEO

Dr. Fatima Bennai-Sanfourche

Bayer

Director Medical device Safety, Medical Device Safety Officer

Elijahu Berkovich

Clexio Biosciences

Head of Emerging Science and Innovation

Beate Bittner

Roche

Product Optimization Franchise Leader

Jace Blackburn

Genentech

Smart Device Engineer

Jeffrey T. Blue

MSD

Executive Director, Vaccine Drug Product Development PR&D

Erwan Bourles

GSK

Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit

Dr. Stefan Bracht

Bayer

Vice President Head of Disruptive Technologies

Klaus Brandenburg

Forschungszentrum Borstel

CSO of Brandenburg Antiinfektiva,

Olivier Brass

Sanofi

Senior scientist, lead of research unit, research department

Sebastian Braun

LTS LOHMANN Therapie-Systeme AG

Director - Head of Formulation Development and Head of Manufacturing for Innovative Injection Systems

David Brayden

University College Dublin

Full Professor (Advanced Drug Delivery)

Chairperson Room 3

Scott Brown

MSD

Executive Director Device Development

Camilla Foged

University of Copenhagen

Professor Vaccine Design and Delivery Group

Twinkle Christian

Amgen

Process Development Scientist, Drug Product Technologies Group

David Cipolla

Insmed Inc.

Vice President of Research

Matthew Clemente

Novo Nordisk

Corporate Vice President Delivery Systems Engineering

Bernardo Cordovez

Halo Labs

Chief Science Officer and Founder

Andrea Cusack

LEON-NANODRUGS GMBH

Chief Executive Officer

Frederic Dargelas

DelSiTech

Director, Head of Business Development and Alliance Management

Ranjit Dhenge

GlaxoSmithKline

Investigator R&D

Ryan F. Donnelly

Queen's University Belfast

Chair in Pharmaceutical Technology

Sachin Dubey

Ichnos Sciences SA

Senior Associate Director, Drug product and Analytical Development

Alina Dumitru

Imperial College London

PhD Researcher

Gabriele Sadowski

TU Dortmund

Professor for Thermodynamics

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Chairperson Room 2

Rob Gelissen

W. L. Gore & Associates – PharmBIO Division

Business Development for Drug Delivery and Packaging

David Grant

Enesi Pharma

Head of Device Development

Mark Guarraia

Novo Nordisk

Vice President, Design and User Experience

Heinrich Haas

BioNTech

Vice President, Formulation

James Hance

Oval Medical Technologies Ltd

Senior Device Development Engineer

Robert Hennig

Merck

Associate Director Drug Delivery & Innovation, Healthcare R&D

João Henriques

Hovione

Group Leader, R&D Drug Product Development

Korinde van den Heuvel

DFE pharma

Senior Product Developer

David Hipkiss

Enesi Pharma

Chief Executive Officer

Martin Hofsäss

BASF SE

PostDoc Development Pharma Solutions

Shiqi Hong

Roquette

Senior biopharma scientist

Kristiina M. Huttunen

University of Eastern Finland

Adjunct Professor (Docent) and Finnish Academy Research Fellow

Alba Córdoba Insensé

Nanomol Technologies S.L.

Technology Transfer & BD Director

Lynne A. Isopi

MSD

Principal Scientist, Vaccine Drug Product Development

Lynne Isopi

Merck

Scientist

Christian Jones

Nanoform

Chief Commercial Officer

Chairperson Room 1, Day 1

Arul Joseph

Avanir Pharmaceuticals

Senior Director, Pharmaceutical Development and Clinical Supply Chain

Nitin Joshi

Brigham and Women’s Hospital, Harvard Medical School

Instructor of Anesthesia, Center for Nanomedicine

Dr. Nazila Kamaly

Imperial College London

Lecturer, Chemistry

Karsten Fluegel

Merck

Postdoctoral Researcher | Drug Delivery & Innovation

Naila El Kechai

Sanofi

Formulation and Drug Product Team Leader

Dr Martin Körber

Pensatech Pharma GmbH

Director Research & Development

Satu Lakio

Nanoform

Pharmaceutical Development Director

Dr Garry Laverty

Queen’s University Belfast

Senior Lecturer in Pharmaceutical Sciences

Jayne Lawrence

NoWCADD, University of Manchester

Director

Philippe Leferve

Roquette

Head of Global CTS Labs

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Philippe Lienard

Sanofi

Pre-Development Science Leader

Tony Listro

Foster Delivery Science

Vice President, Technology

Rosario LoBrutto

Sandoz

Head of Scientific Affairs

Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr. Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr Fiona MacDougall

BDD

Director of Biopharmaceutics

Kenneth J. Mandell

LayerBio

Founder and CEO

Giuseppe Manini

ULB

PhD student

Lena Mareczek

Merck

PhD candidate

Moein Moghimi

Newcastle University

Professor of Nanomedicine

Fadee Mondalek

Bayer

Head of internal development

Anne Moore

University College Cork

Professor

Anette Müllertz

University of Copenhagen

Professor, Head of Center

Vishal Nashine

BMS

Director Pipeline & Product Lifecycle Strategy (PPLS)

Celine Ollier

Sanofi

PK-Biopharm Marketed Compounds

Luis Padrela

University of Limerick

Lecturer SSPC, Bernal Institute

Mafalda Paiva

Hovione

Group Leader, R&D Analytical Development

Ravi Pamnani

Intact Therapeutics, Inc

Founder/CEO

Rick Panicucci

QED Therapeutics

Senior Vice President CMC

Luigi Boltri, Ph.D.

Adare Pharma Solutions

Senior. Director Pharmaceutical Sciences, Business Support and New Technologies,

Carolin Riehl

Merck

Principal Scientist | Lab Head Drug Delivery & Innovation

Christophe Roberge

MedinCell

Senior Technology Advisor

Dr. Ines Rüstenberg

Sensile Medical, a Gerresheimer company

Director Development

Niklas Sandler

Nanoform

Chief Technology Officer

Chairperson Room 1, Day 3

Dr Ana L Gomes dos Santos

AstraZeneca

Principal Scientist

Luis Santos

AstraZeneca

Drug Delivery Leader, Biopharmaceutical Development, Cell and Gene Therapies, Innovation

Stefan Schneid

Bayer

Laboratory Head Formulation Development Parenterals

John C. Shelley

Schrödinger

Fellow

Dr. Johanna Simon

Merck

Scientific Expert Analytical and Preparative Liquid Chromatography

Sarah Stevens

Quotient Sciences

Vice President, Drug Development Sciences

Aaron Stewart

Lonza

Associate Principal Scientist

Juliet Symonds

GSK

Investigator

Emilie Tabare

ULB

PhD student

Dr. Timo Taghizadeh

tesa Labtec GmbH

Head of Business Development & Marketing

Stephen Tindal

Catalent

Director of Science & Technology

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Ijeoma F. Uchegbu

University College London

Chair in Pharmaceutical Nanoscience

Alex Vasiev

Oval Medical Technologies

Manager of Device Development

Bharathi Vellalore

Janssen

Scientist, Drug Product Development Discovery, Product Development and Supply

Murty Vyakarnam

Oculinea Inc

Co-founder & Chief Executive Officer

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Shogo Warashina

SE Tylose GmbH & Co.KG

Technical Sales Manager

Daryl Williams

Imperial College

Professor of Particle Science

Latest News

Nanoform’s Clinical Study Indicates Positive Interim Results

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.
×